CalciMedica is trading 6.11% higher at $1.39 in after-hours on October 8, with no company-specific announcement identified.
- CalciMedica closed the regular session at $1.31, down 11.49%.
- The company’s investor-relations page lists September 8 as its latest 2026 release.
- Broader risk-off conditions and biotech weakness were reported, but available evidence does not establish them as the cause of the after-hours rebound.